Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase I/II Study to Evaluate the Safety and Tolerability of LiPlaCis in Patients With Advanced or Refractory Tumours (LiPlaCis)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01861496
Recruitment Status : Active, not recruiting
First Posted : May 23, 2013
Last Update Posted : July 28, 2021
Sponsor:
Information provided by (Responsible Party):
Allarity Therapeutics

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : October 2021
Estimated Study Completion Date : October 2021